Stay updated with breaking news from Graybug Vision. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The global retinal vein occlusion treatment market is likely to register a CAGR of 5.9% from 2023 to 2033. According to Future Market Insights, a valuation of US$ 2.3 billion is expected for the industry by the end of 2023. Retinal vein occlusion is among the most pervasive retinal vascular ailments in older individ...
Dublin, March 14, 2023 (GLOBE NEWSWIRE) -- The "Retinal Disorder Treatment Market Size, Share & Trends Analysis Report By Type (Macular Degeneration,...
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed merger of Graybug Vision, Inc. with CalciMedica Inc.... | February 14, 2023
The global retinal vein occlusion therapy market is predicted to be worth US$ 2.3 billion in 2023, with a compound yearly growth rate (CAGR) of 5.9% to reach US$ 4.7 billion by 2033. Retinal vein occlusion is one of the most common retinal vascular disorders in the elderly, affecting adults over the age of 65. Age i...
Tech companies, Seoul Robotics USA, SpyGlass Pharma Inc., Mammogen Inc., Diality Inc., Syntr Health Technologies Inc., have new launches